#China #Shenzhen #AI Integration #Diabetes Care #SIBIONICS

SIBIONICS Hosts Fourth AGP & DTx Summit in Shenzhen

Recently, SIBIONICS held its fourth AGP & DTx Summit in Shenzhen, gathering nearly 300 experts from various fields including clinicians, researchers, and industry partners. This summit aimed to explore the next steps in the digital management of diabetes.

Theme of the Summit

The overarching theme for this year's summit was "Beyond Glucose: The Integrated Future of CGM, CKM, and AI in Diabetes." This focus emphasized the essential role that Continuous Glucose Monitoring (CGM), Continuous Ketone Monitoring (CKM), digital therapies, and artificial intelligence (AI) play in evolving clinical practices and patient-centered care.

Key Discussions and Presenters

Over 30 international speakers participated in the event, presenting insights on various topics. Notable speakers included Andrej Janež, Sofianos Andrikopoulos, Shannon Lin, and Rodrigo Nunes Lamounier. The diverse range of topics addressed included the application and medical-economic value of digital therapies in diabetes, metabolic phenotyping based on CGM, challenges and perspectives surrounding CGM technology, and patient expectations regarding CGM and digital diabetes management.

Specialized Academic Sessions

In addition to the main forum, the summit included three parallel academic sessions: a clinical session, a nursing session, and a session showcasing exemplary clinical case studies. These sessions offered a multidisciplinary platform for exchanging ideas, covering clinical research, nursing practices, real-life applications, and patient management strategies. A central theme throughout the discussions was the shift from mere glucose monitoring to a more integrated and proactive approach to diabetes management.

Integration of AI in Diabetes Care

With advancements in AI-driven tools, CGM data is increasingly being connected to daily behaviors such as meal patterns, physical activity, and medication adherence. This integration aims to help both users and healthcare professionals better understand glucose profiles and management needs.

During the summit, SIBIONICS introduced the AI capabilities integrated into its GS3 system, featuring AI Meal Insight and AI-assisted event logging. These features are designed to simplify daily tracking, analyze links between lifestyle habits and glycemic variations, and improve long-term adherence.

Conclusion

As the summit concluded, it became clear that the innovations presented signal a new era in diabetes care, driven by AI and digital technologies. SIBIONICS is leading the charge, bridging the gap between technology and patient care, ultimately paving the way for more effective management strategies for diabetes. This event not only highlighted current advancements but also the collaborative future that awaits in the realm of diabetes management.

For additional insights and updates from the summit, please refer to the full press release and subsequent materials that detail the ongoing work in this ever-evolving field.